Table 2 Comparison between patients discontinuing infliximab or azathioprine.
IFX withdrawal group (n = 15) | AZA withdrawal group (n = 10) | IFX and AZA withdrawal group (n = 6) | P-value | |
|---|---|---|---|---|
Sex, male (%) | 7 (31.80) | 9 (40.90) | 6 (27.30) | 0.018Chi |
At diagnosis | ||||
White blood cell count, × 103/μL | 7.80 (7.43, 9.71) | 9.29 (8.23, 10.72) | 8.61 (7.80, 9.19) | 0.673 K |
Hematocrit, % | 35.60 (33.10, 39.10) | 35.20 (32.30, 39.10) | 40.00 (37.90, 41.70) | 0.069 K |
ESR, mm/h | 53.00 (41.50, 78.0) | 63.00 (39.30, 83.50) | 25.00 (23.00, 29.30) | 0.071 K |
C-reactive protein, mg/dL | 1.21 (0.64, 7.60) | 2.37 (1.84, 3.52) | 2.33 (1.10, 3.46) | 0.712 K |
Albumin, g/dL | 3.80 (3.60, 4.30) | 3.80 (3.50, 4.30) | 4.20 (4.00, 4.40) | 0.479 K |
PCDAI at diagnosis | 40.00 (33.30, 46.30) | 35.00 (30.60, 41.90) | 35.00 (30.00, 41.00) | 0.515 K |
SES-CD at diagnosis | 16.00 (11.50, 19.50) | 18.00 (14.30, 24.00) | 13.50 (7.00, 17.80) | 0.298 K |
At IFX or AZA withdrawal | ||||
White blood cell count, × 103/μL | 5.52 (4.80, 7.07) | 6.11 (5.45, 6.88) | 5.67 (5.11, 5.82) | 0.830 K |
Hematocrit, % | 39.40 (37.10, 43.80) | 45.40 (44.50, 46.60) | 43.20 (42.50, 45.50) | 0.174 K |
ESR, mm/h | 12.00 (4.50, 20.50) | 4.50 (2.30, 9.00) | 5.00 (2.80, 11.80) | 0.243 K |
C-reactive protein, mg/dL | 0.03 (0.03, 0.08) | 0.04 (0.03, 0.04) | 0.13 (0.03, 0.36) | 0.437 K |
Albumin, g/dL | 4.50 (4.40, 4.70) | 4.70 (4.60, 4.90) | 4.50 (4.50, 4.60) | 0.196 K |
PCDAI at drug withdrawal | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0.669 K |
SES-CD at drug withdrawal | 0 (0, 0.45) | 0 (0, 0) | 0 (0, 0.25) | 0.496 K |